Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication

7 Sept 2005

Abstract excerpt

Interferon alpha (IFN-alpha)-based therapy is the currently approved treatment for chronic hepatitis C viral infection. The sustained antiviral response rate is approximately 50% for genotype-1 infection. The major challenge to the HCV community is to improve antiviral efficacy and to reduce the side effects typically seen in IFNalpha-based therapy. One of the strategies is to identify new interferons, which may...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokine Signaling Pathways and Interactions
Share to Hepatitis C virus research
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16146571
DOI: 10.1186/1743-422x-2-80

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replicationPMID 16146571Read ↗

Investigation into the role of novel interferon lambdas in the treatment of viral disease, primarily hepatitis CSemantic proximity Read ↗

Distinct and overlapping genomic profiles and antiviral effects of Interferon‐λ and ‐α on HCV‐infected and noninfected hepatoma cellsSemantic proximity Read ↗

IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway.Semantic proximity Read ↗

Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virusSemantic proximity Read ↗

Lambda Interferon Inhibits Hepatitis B and C Virus ReplicationSemantic proximity Read ↗

Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting AntiviralsSemantic proximity Read ↗

Interferon-lambda and therapy for chronic hepatitis C virus infection.Semantic proximity Read ↗

λ‐Interferons and the single nucleotide polymorphisms: A milestone to tailor‐made therapy for chronic hepatitis CSemantic proximity Read ↗

Hepatitis C Virus Infection Induces the Beta Interferon Signaling Pathway in Immortalized Human HepatocytesSemantic proximity Read ↗

Interferons, interferon‐like cytokines, and their receptorsSemantic proximity Read ↗

Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.Semantic proximity Read ↗

Ribavirin Regulates Hepatitis C Virus Replication Through Enhancing Interferon-Stimulated Genes and Interleukin 8Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.